Semaglutide administration has been linked to an increased incidence of suicidal tendencies
American, Italian, and Swiss researchers conducted a case-control study and found that taking the glucagon-like peptide-1 (GTP-1) receptor agonist semaglutide was associated with a disproportionately increased incidence of suicidal tendencies
14.11.2024